What is the recommended dosing regimen for Seroquel XR (quetiapine extended‑release) in an adult with schizophrenia or other psychotic disorder, including starting dose, titration schedule, target and maximum doses, and adjustments for elderly or hepatic impairment?

Seroquel XR Dosing for Psychosis in Adults

Recommended Dosing Regimen for Schizophrenia

For adults with schizophrenia, Seroquel XR should be initiated at 300 mg once daily on Day 1, increased to 600 mg on Day 2, with a target dose of 400–800 mg once daily reached by Day 3, allowing rapid achievement of therapeutic levels while maintaining tolerability. 1, 2

Starting Dose and Titration Schedule

• Day 1: Start with 300 mg once daily in the evening 1, 2
• Day 2: Increase to 600 mg once daily 1, 2
• Day 3 onward: Adjust to 400–800 mg once daily based on clinical response and tolerability 1, 2
• This rapid escalation schedule is well tolerated and achieves a therapeutically effective dose by Day 2 1

Target and Maximum Doses

• Target dose range: 400–800 mg once daily 1, 2
• Maximum dose: 800 mg once daily 1, 2
• Clinical efficacy is dose-related, with maximum effects occurring at dosages ≥250 mg/day 3
• Doses of 400–800 mg/day have demonstrated effectiveness versus placebo across a broad range of symptom domains in acute schizophrenia 1

Conversion from Immediate-Release Quetiapine

• Clinically stable patients receiving quetiapine immediate-release (IR) 400–800 mg/day can be switched directly to an equivalent once-daily dose of Seroquel XR (400–800 mg once daily) without clinical deterioration or compromise in tolerability 1

Special Population Adjustments

Elderly Patients

• Starting dose: 25 mg once daily 3
• Titration: Increase by 25–50 mg daily increments to reach an effective dose 3
• Target dose: Lower than standard adult dosing; the effective dose is likely to be in the lower range 3
• Elderly patients demonstrate 20–30% higher maximum plasma concentrations and up to 50% lower oral clearance compared to younger patients 3
• Patients over 75 years respond less well to antipsychotics, particularly olanzapine, and require cautious dosing 4

Hepatic Impairment

• Starting dose: 25 mg once daily 5, 3
• Titration: Increase by 25–50 mg daily increments with caution 5, 3
• Mean oral clearance is reduced by approximately 25% in patients with hepatic cirrhosis compared to healthy controls 5, 3
• Inter-subject variability in quetiapine clearance is noted in cirrhotic patients, necessitating careful dose escalation 5
• No change is needed in the recommended starting dose of 25 mg, but subsequent titration should proceed cautiously 5

Renal Impairment

• No dosage adjustment is necessary for patients with renal impairment based on pharmacokinetic studies 5, 3
• Mean oral clearance is reduced by approximately 25% in patients with severe renal impairment, but this does not require routine dose modification 5, 3
• A starting dose of 25 mg/day with cautious titration is recommended as a conservative approach 3

Key Clinical Considerations

Efficacy Profile

• Quetiapine XR is effective against both positive and negative symptoms of schizophrenia 6, 1
• Improvements in overall psychopathology are maintained for at least 52 weeks in open-label follow-up studies 6
• The drug improves cognitive function, depressive symptoms, and hostility/aggression 6

Tolerability Advantages

• Quetiapine is associated with placebo-level incidence of extrapyramidal symptoms (EPS) across its entire dose range 6, 3
• Unlike risperidone and amisulpride, quetiapine does not elevate plasma prolactin levels compared to placebo 6, 3
• The drug has minimal short-term effects on body weight and a favorable long-term weight profile 6
• Common adverse events include headache (19.4%), somnolence (17.5%), and dizziness (9.6%) 3

Switching from Other Antipsychotics

• Patients with schizophrenia who had unsatisfactory treatment (tolerability or efficacy) on typical or atypical antipsychotics experienced improved efficacy and clinical benefit when switched to Seroquel XR 1, 2
• Patients can be switched from their ongoing antipsychotic to Seroquel XR within 4 days, enabling doses of 600 mg/day and 800 mg/day to be reached by Day 2 and Day 3, respectively 1

Common Pitfalls to Avoid

• Do not use slower titration schedules in acute psychosis, as the rapid initiation scheme (300 mg Day 1,600 mg Day 2, up to 800 mg Day 3) is well tolerated and achieves therapeutic levels faster 1, 2
• Do not exceed 800 mg once daily, as this is the established maximum dose 1, 2
• Do not assume elderly or hepatically impaired patients require the same starting dose; always begin at 25 mg daily in these populations 5, 3
• Do not discontinue abruptly after long-term use; taper gradually to minimize withdrawal symptoms 3